Literature DB >> 2861420

Progressive liver disease in haemophilia: an understated problem?

C R Hay, F E Preston, D R Triger, J C Underwood.   

Abstract

In an 8-year study of 79 unselected patients with haemophilia who had received clotting factor concentrates, there was evidence of chronic progressive liver disease in at least 17 (21%). 8 patients had chronic active hepatitis and 9 had cirrhosis (5 with oesophageal varices). Histological evidence suggested that non-A non-B hepatitis was mainly responsible, although the influence of other viruses could not be excluded. Serial liver biopsies showed progression from chronic persistent hepatitis to chronic active hepatitis and cirrhosis within 6 years, suggesting that chronic persistent hepatitis in haemophiliacs is not as benign as hitherto supposed. Symptoms and abnormal physical signs were uncommon in these patients. There was no relation between degree of abnormality of serum aminotransferase levels and severity of the underlying liver disease. It is anticipated that liver disease in haemophiliacs will become an increasing clinical problem in the future.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2861420     DOI: 10.1016/s0140-6736(85)92264-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  16 in total

1.  Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection.

Authors:  E Bierhoff; H P Fischer; E Willsch; J Rockstroh; U Spengler; H H Brackmann; J Oldenburg
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

Review 2.  Blood transfusion and hepatitis: still a threat?

Authors:  H W Reesink; C L van der Poel
Journal:  Blut       Date:  1989-01

3.  Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs.

Authors:  M G Ghany; C Leissinger; R Lagier; R Sanchez-Pescador; A S Lok
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

Review 4.  Hemophilia treatment in historical perspective: a review of medical and social developments.

Authors:  F R Rosendaal; C Smit; E Briët
Journal:  Ann Hematol       Date:  1991-02       Impact factor: 3.673

5.  Hepatitis C and haemophilia.

Authors:  P R Foster; R V McIntosh; A J MacLeod
Journal:  BMJ       Date:  1995-09-16

Review 6.  Hepatitis C virus and transfusion transmitted liver disease: review.

Authors:  J C Underwood
Journal:  J Clin Pathol       Date:  1990-06       Impact factor: 3.411

7.  Interferon-alpha therapy for chronic hepatitis C in special patient populations.

Authors:  P Marcellin; N Boyer; J P Behamou; S Erlinger
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

Review 8.  Patterns of progression: unpredictability and risk of decompensated cirrhosis.

Authors:  N C Tassopoulos
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

9.  HTLV-III, haemophilia and blood transfusion.

Authors:  V E Mitchell; C Martin; A J Flower
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-20

10.  Interferon treatment of chronic hepatitis C in patients with hemophilia or von Willebrand's disease in Japan.

Authors:  M Yoshikawa; H Fukui; H Kojima; H Yoshiji; T Sakamoto; H Imazu; T Nakanani; Y Matsumura; S Kuriyama; J Yamao
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.